A Phase I study of iPS-NKT cell intra-arterial infusion therapy in patients with recurrent or advanced head and neck cancer

General Information

Clinical trials phase Phase 1
Start date (estimated) 2020-09-11
Clinical feature
Label head and neck cancer
Link http://purl.obolibrary.org/obo/DOID_11934
Description An organ system cancer that arises in the head or neck region. This region includes the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx.

Administrative Information

ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCT2033200116
Other study identifiers
Name jRCT2033200116
Description Japan Registry of Clinical Trials (jRCT)
Source weblink https://jrct.niph.go.jp/en-latest-detail/jRCT2033200116
Public contact
Email t-fujiwara@chiba-u.jp
Public email t-fujiwara@chiba-u.jp
First name Tadami
Last name Fujiwara
Phone +81-43-222-7171
City Chiba
Address freetext Chiba University Hospital Dept. of Otorhinolaryngology, Head and Neck Surgery, Chiba University Hospital 1-8-1 Inohana, Chuo-ku, Chiba, 260-0856 Japan


Which differentiated cell type is used
Label natural killer cell
Link http://purl.obolibrary.org/obo/CL_0000623
Description A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.


Recruitment Status Recruiting
Estimated number of participants 9
Contact institutions/departments